153
Views
18
CrossRef citations to date
0
Altmetric
Original Research

In vitro and in vivo antimicrobial activity of combined therapy of silver nanoparticles and visible blue light against Pseudomonas aeruginosa

, , &
Pages 1749-1758 | Published online: 27 Apr 2016

References

  • MahendraRAlkaYAniketGSilver nanoparticles as a new generation of antimicrobialsBiotechnol Adv200927176183
  • D’BrittoVKapseHBabrekarHSilver nanoparticle studded porous polyethylene scaffolds: bacteria struggle to grow on them while mammalian cells thriveNanoscale2011372957296321643585
  • NowackBKrugHHeightM120 years of nanosilver history: 609 Implications for policy makersEnviron Sci Technol20114541177118321218770
  • BogumiłaRAndreaHAndreasLKennethADIseultLMechanisms of silver nanoparticle release, transformation and toxicity: A critical review of current knowledge and recommendations for future studies and applicationsMaterials2013622952350
  • XiuZMZhangQBPuppalaHLColvinVLAlvarezPJJNegligible particle-specific antibacterial activity of silver nanoparticlesNano Lett20121284271427522765771
  • DaiTGuptaAMurrayCKVrahasMSTegosGPHamblinMRBlue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond?Drug Resist Updat201215422323622846406
  • MacleanMMcKenzieKAndersonJGGettinbyGMacGregorSJ405 nm light technology for the inactivation of pathogens and its potential role for environmental disinfection and infection controlJ Hosp Infect201488111125066049
  • FiliceGANymanJALexauCExcess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infectionInfect Control Hosp Epidemiol201031436537320184420
  • MauldinPDSalgadoCDHansenISDurupDTBossoJAAttributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant Gram-negative bacteriaAntimicrob Agents Chemother201054110911519841152
  • MétrauxGSMirkinCARapid thermal synthesis of silver nanoprisms with chemically tailorable thicknessAdv Mater2005174412415
  • KapoorSPreparation, characterization, and surface modification of silver particlesLangmuir199814510211025
  • Clinical Laboratory Standard Institute (CLSI)Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standards-Second Edition, in CLSI document M27-2APennsylvania, USACLSI2002
  • DykstraMJReussEBiological Electron Microscopy Theory, Techniques and Troubleshooting2nd edGermanySpringer2003
  • RupalJKaushaJMallikarjunaSCDiptPPreparation and evaluation of topical gel of valdecoxibInt J Pharm Sci Drug Res2010215154
  • BisbeJGatellJMPuigJPseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodesRev Infect Dis1988106296353393785
  • VidalFMensaJAlmelaMEpidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodesArch Intern Med1996156212121268862105
  • TammaPDCosgroveSEMaragakisLLCombination therapy for treatment of infections with Gram-negative bacteriaClin Microbiol Rev20122545047022763634
  • HillDRoseBPajkosAAntibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditionsJ Clin Microbiol200543105085509016207967
  • FranciGFalangaAGaldieroSSilver nanoparticles as potential antibacterial agentsMolecules2015208856887425993417
  • ElechiguerraJLBurtJLMoronesJRInteraction of silver nanoparticles with HIV-1J Nanobiotechnology20053615987516
  • CromwellWAYangJStarrJLJoYKNematicidal effects of silver nanoparticles on root-knot nematode in bermudagrassJ Nematol201446326126625275999
  • PereiraLDiasNCarvalhoJFernandesSSantosCLimaNSynthesis, characterization and antifungal activity of chemically and fungal-produced silver nanoparticles against Trichophyton rubrumJ Appl Microbiol201411761601161325234047
  • ChoiOHuZSize dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteriaEnviron Sci Technol2008424583458818605590
  • ZhangMZhangKDe GussemeBVerstraeteWFieldRThe antibacterial and anti-biofouling performance of biogenic silver nanoparticles by Lactobacillus fermentumBiofouling20143034735724564796
  • LazarVQuorum sensing in biofilms – How to destroy the bacterial citadels or their cohesion power?Anaerobe20111728028521497662
  • PeriasamySJooHSDuongACHow Staphylococcus aureus biofilms develop their characteristic structureProc Natl Acad Sci20121091281128622232686
  • MoronesJRElechiguerraJLCamachoAThe bactericidal effect of silver nanoparticlesNanotechnology2005162346235320818017
  • MatsumuraYYoshikataKKunisakiSTsuchidoTMode of bacterial action of silver zeolite and its comparison with that of silver nitrateAppl Environ Microbiol2003694278428112839814
  • SukumaranPEldhoKPSilver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effectsInt Nano Lett2012232
  • MacleanMMacgregorSJAndersonJGWoolseyGAThe role of oxygen in the visible-light inactivation of Staphylococcus aureusJ Photochem Photobiol B200892318018418657991
  • WuLMcGraneRSBeattieGALight regulation of swarming motility in Pseudomonas syringae integrates signaling pathways mediated by a bacteriophytochrome and a LOV proteinMBio201343e00334e1323760465
  • BarkovitsKSchubertBHeineSScheerMFrankenberg-DinkelNFunction of the bacteriophytochrome BphP in the RpoS/Las quorum sensing network of Pseudomonas aeruginosaMicrobiology2011157Pt 61651166421415115
  • DonlanRMCostertonJWBiofilms: Survival mechanisms of clinically relevant microorganismsClin Microbiol Rev20021516719311932229
  • MoskowitzSMFosterJMEmersonJBurnsJLClinically feasible bio-film susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosisJ Clin Microbiol2004421915192215131149
  • CostertonJWStewartPSGreenbergEPBacterial biofilms: a common cause of persistent infectionsScience199928454181318132210334980
  • ScherKRomlingUYaronSEffect of heat, acidification, and chlorination on Salmonella enterica serovar typhimurium cells in a biofilm formed at the air-liquid InterfaceAppl Environ Microbiol20057131163116815746314
  • RoeDKarandikarBBonn-SavageNGibbinsBRoulletJBAntimicrobial surface functionalization of plastic catheters by silver nanoparticlesJ Antimicrob Chemother20086186987618305203
  • StevensKNCroesSBoersmaRSHydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous cathetersBiomaterials2011321264126921093906
  • MahmoudiMSerpooshanVSilver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threatACS Nano201262656266422397679
  • ChurchDElsayedSReidOWinstonBLindsayRBurn wound infectionsClin Microbiol Rev200619240343416614255
  • World Health Organization (WHO)Model List of Essential Medicines, 19th list2015 Available from: http://www.who.int/medicines/publications/essentialmedicines/en/Accessed November 10, 2015
  • NunanRHardingKGMartinPClinical challenges of chronic wounds: searching for an optimal animal model to recapitulate their complexityDis Model Mech20147111205121325359790
  • ZhaoGUsuiMLLippmanSIBiofilms and inflammation in chronic woundsAdv Wound Care201327389399
  • WestgateSJPercivalSLKnottenbeltDCCleggPDCochraneCAMicrobiology of equine wounds and evidence of bacterial biofilmsVet Microbiol201112150152
  • FjordbakkCTArroyoLGHewsonJRetrospective study of the clinical features of limb cellulitis in 63 horsesVet Rec2008162823323618296664